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Abstract Metabolomics has become a crucial phenotyp-
ing technique in a range of research fields including medi-
cine, the life sciences, biotechnology and the environmental
sciences. This necessitates the transfer of experimental in-
formation between research groups, as well as potentially to
publishers and funders. After the initial efforts of the meta-
bolomics standards initiative, minimum reporting standards
were proposed which included the concepts for metabo-
lomics databases. Built by the community, standards and
infrastructure for metabolomics are still needed to allow
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storage, exchange, comparison and re-utilization of meta-
bolomics data. The Framework Programme 7 EU Initiative
‘coordination of standards in metabolomics’ (COSMOS) is
developing a robust data infrastructure and exchange stan-
dards for metabolomics data andmetadata. This is to support
workflows for a broad range of metabolomics applications
within the European metabolomics community and the
wider metabolomics and biomedical communities’ par-
ticipation. Herewe announce our concepts and efforts asking
for re-engagement of the metabolomics community, aca-
demics and industry, journal publishers, software and
hardware vendors, as well as those interested in stan-
dardisation worldwide (addressing missing metabolomics
ontologies, complex-metadata capturing and XML based
open source data exchange format), to join and work towards
updating and implementing metabolomics standards.
Keywords Metabolomics  Metabonomics  Data
standards  Data exchange  e-Infrastructure  Coordination
and data sharing community
1 Introduction
Metabolomics (Bundy et al. 2009; Clayton et al. 2006;
Eckhart et al. 2012; Holmes et al. 2008)1 and fluxomics
(metabolic flux analysis, Zamboni, Nicola et al. ‘‘13C-based
metabolic flux analysis.’’ Nature protocols 4.6 (2009):
878–892) measurements mark the end point closest to the
phenotype of organisms, reflecting changes in organisms
influenced by external parameters such as nutritional, envi-
ronmental or toxicological interactions. In this context, due
to its dynamic nature, metabolomics is of considerable value
for examples in personalised medicine, especially as it
captures rapid responses close to the phenotype and in
concert with the genome, transcriptome and epigenome (van
der Greef et al. 2006, Nicholson et al. 2011). For such
methods to succeed in a personalised medicine context, ro-
bust traceable standardisation is essential, covering storage
and exchange of metabolomics and fluxomics data. More-
over, new applications that link metabolomics and biobanks
are emerging: metabolomics may be used as an efficient tool
to monitor the quality of stored samples and to establish the
optimal standard operating procedures (SOPs) for the pre-
analytical handling of bio-specimens (Bernini et al. 2011).
Metabolomics is rapidly becoming an essential tool in the
screening of food products, which is highly regulated and
follows standard guidelines. Furthermore it is being inves-
tigated as a potentially transformative technology for the
screening of chemical safety, not only for traditional
industrial and domestic chemicals but also for the safety
assessments of engineered nanomaterials as well as novel
compounds generated through synthetic biology.
Considering the diversity and breadth of metabolomics
applications, not forgetting complexity and diversity of the
analytical technologies in use, there is a clearly identified
need for standardisation that evolves with the technologies
and is sufficiently inclusive to cover all metabolomics
applications.
2 What has been achieved so far in metabolomics
standards
The momentum for metabolomics standards started in
2004–2005 with initiatives such as the standard metabolic
reporting structure initiative or SMRS (Lindon et al. 2005)
and the Architecture for Metabolomics consortium or
Armet (Jenkins et al. 2004); these were mainly focused on
an aspect of metabolomics standards, for example nuclear
magnetic resonance (NMR) based metabonomics or plant-
based metabolomics. There were several other initiatives at
the time, however all efforts eventually resulted in the
formation of the metabolomics standards initiative (MSI)
in 2005 (Castle et al. 2006; Fiehn et al. 2006). This was
focused on community-agreed minimum reporting stan-
dards and providing initial efforts on the descriptions of the
experimental metadata describing a metabolomics study.
This culminated in a series of manuscripts published in
2007 that considered all the components undertaken in
metabolomics experiments (Sansone et al. 2007; Fiehn
et al. 2007; Hardy and Taylor 2007) summarized in
(Goodacre 2014). One major outcome was the formation of
five different working groups (WG) to consider each aspect
of the metabolomic pipeline; biological context metadata
WG, chemical analysis WG, data processing WG, ontology
WG and exchange format WG, with the task of collecting
relevant metabolomics standards and a forum for discus-
sion (Goodacre et al. 2007; Morrison et al. 2007; Rubtsov
et al. 2007; Sumner et al. 2007; Werf et al. 2007). How-
ever, there have been limited practical applications for such
descriptions, with some exceptions (Ludwig et al. 2012;
Bais et al. 2010; Ferry-Dumazet et al. 2011; Griffin et al.
2011; Scholz and Fiehn 2007), in part owing to a lack of
tools to facilitate implementation or a widely used database
to enforce such standards. Most projects or databases fo-
cused on one particular technology or limited to a par-
ticular species or type of analytical technique. In order to
implement agreed and acceptable guidelines on reporting
identified metabolites, an application platform such as
database i.e. a metabolomics repository in addition to a
journal publication is required. 2012 saw the release of
MetaboLights (http://www.ebi.ac.uk/metabolights), the
1 ‘‘Metabolome | Metabolomics Definition | InTechOpen.’’ 2012. 20
Aug. 2013 http://www.intechopen.com/books/metabolomics.
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first general purpose database in metabolomics, developed
and maintained by the European Bioinformatics Institute
(EMBL-EBI), one of the largest open access data providers
in the world (Haug et al. 2013; Salek et al. 2013a).
MetaboLights combines small molecule ‘reference’ layer
with information about individual metabolites, their
chemistry, spectrometry and biological roles with a study
archive, where primary data and metadata from metabo-
lomics studies are ontologically tagged and stored. Such
depositions receive a stable identifier for each study, which
can be quoted in related publications and can be used to
access the data long term. Making metabolomics data
publicly accessible allows it to justify researchers’ findings
in a peer-reviewed publication, increases the possibility of
wider collaborations within the metabolomics community
and ultimately gives a study higher visibility and increased
citation (Nature Genetics 2009). MetaboLights adheres to
MSI standards and uses the Investigation/Study/Assay
(ISA) tab-delimited format (Rocca-Serra et al. 2010),
which makes it interoperable with a large number of other
ongoing projects dealing with biological study data, in-
cluding other ‘omics datasets. Specific scientific fields have
developed their own systems biology solutions (e.g. dbNP
developed by NuGO, covering the Nutritional Phenotype),
and the metabolomics data of such sites should be made
exchangeable with other metabolomics databases (for in-
stance by implementing an export to ISA-Tab format for
the study metadata as well as exporting the results).
3 COSMOS: the way forward in standards
The FP7 EU Initiative ‘coordination of standards in meta-
bolomics’ (COSMOS) brings together leading vendors,
researchers and bioinformaticians of the European meta-
bolomics community, members of the MSI, members of the
international Metabolomics Society, along with other
stakeholders worldwide. One of the COSMOS initiative
goals is to develop a robust data infrastructure for metabo-
lomics data and metadata representation and exchange in
order to support workflows for a broad range of metabo-
lomics applications (Salek et al. 2013b; Steinbeck et al.
2012). The potential of metabolomics cannot be harvested
without major standardisation of formats and terminologies,
therefore we leverage on and extend earlier efforts initiated
by the MSI and currently operating under the Metabolomics
Society, in part via that society’s dedicated Data Standards
task group. As is the case for other high-throughput
‘‘-omics’’ disciplines, metabolomics is seeing a paradigm
shift from hypothesis-driven to data-driven science (Cox
and Mann 2011; Goodacre et al. 2004). As a result, meta-
bolomics data are constantly growing with a plethora of
analysis tools. Cross-site data comparison remains a
challenging task due to the different access modalities for
the different local repositories. Hence, currently the gener-
ated data often ends up in data silos or worse as data dumps
or ‘data-graveyards’. This situation constitutes a need for
the establishment of open data standards and accessible
repositories that allow researchers to store, exchange and
compare metabolomics data with pertinent metadata infor-
mation, and thus communicate on a scientific level without
getting stuck in vendor specific data formats. As different
scientific fields continue to develop their own specific so-
lutions, due to specific analytical solutions or meta-data
requirements, COSMOS will invite these fields to adhere to
the general metabolomics standards and export to the
metabolomics solutions developed by COSMOS. To com-
pare data between labs, the data needs to be stored in a way
that allows concise objective interpretation and repro-
ducibility, i.e. the type, origin and treatment of samples and
corresponding spectra needs to be described in an unam-
biguous manner using a common communication channel.
Here, controlled vocabularies (CVs) and ontologies can be
used to standardise the terminology used to represent sci-
entific facts, e.g. tissue or fluid description, sample storage,
preparation and analysis conditions. Another benefit of CVs
are their knowledge representation capabilities, i.e. their
taxonomic backbone that can be exploited to gather more
subsumptive (a more general/abstract) or a more excluding,
search specific attributes.
To work out commonly agreed-upon metabolomics data
standards, the COSMOS initiative coordinates with meta-
bolomics and bioinformatics experts to work on open data
exchange formats (syntax) and data semantics that max-
imize interoperability with other omics standards (Nature
Genetics 2012). This is achieved among other solutions,
by using (i) the general-purpose Investigation/Study/Assay
tabular format or ISA-Tab (Rocca-Serra et al. 2010) for the
experimental information and (ii) adapting the XML-based
formats for the instrument-derived ‘‘raw’’ data types by the
proteomics standards initiative (PSI) (Orchard et al. 2003b;
Orchard et al. 2003a), e.g. mzML (Martens et al. 2011).
Data completeness can then be verified using validator
software enforcing minimum information recommenda-
tions such as the MSI Core Information for Metabolomics
Reporting (CIMR; http://biosharing.org/bsg-000175)
(Sumner et al. 2007). The standardisation efforts in COS-
MOS for nuclear magnetic resonance spectroscopy (NMR)
and mass spectrometry (MS) data, with potential to en-
compass new and alternative technologies as they are de-
veloped, and supporting tools, will form the basis for
funders and publishers to recommend data deposition. The
submitted dataset, in repositories such as MetaboLights
(Haug et al. 2013) or the Netherlands Metabolomics Centre
(NMC) Data Support Platform (DSP) could then be used to
justify findings in a publication. Unlike in other -omics
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domains, as for example ArrayExpress (Parkinson et al.
2009) and Gene Expression Omnibus GEO (Barrett et al.
2013) for transcriptomics, the previous lack of such open,
centralised and persistent data deposition repositories in the
metabolomics field has been criticised by journal editors
who face the tedious task of having to judge whether
conclusions based upon megavariate data are sound and
justified. Here open-access repositories using our stan-
dards, data curation and capture tools, such as the ISA
software suite (Rocca-Serra et al. 2010), as well as others,
will facilitate curation and storage of the metadata at the
source, and streamline submission to MetaboLights. A
growing number of data publication journals, e.g.
BioMedCentral’s GigaScience2 and Nature Publishing
Group’s Scientific Data3 now support the ISA format for
supplementary experimental data and as a means to capture
metadata descriptions. ISA-Tab format is currently in use
and supported by public data repositories such EMBL-EBI
Metabolights (accounting for about 200 datasets, 90 of
which are currently publicly available), but also sever-
al major european toxicogenomics projects (Car-
cinogenomics,4 DiXa5 and InnoMed PredTox and
ToxBank6). These projects fully exploit the capability of
the ISA-Tab format to support an array of assay type al-
lowing to recording multi-omics assays. Furthermore, ISA
developers have a range of tools for converting from var-
ious sources (ArrayExpress,7 SRA8) into ISA-Tab format.
Ultimately, we hope that COSMOS will help experts in
NMR spectroscopy and MS-based metabolomics to com-
municate their results in a more objective comprehensive,
persistent and efficient way, and spanning and integrating
multiple domains such as medical, environmental, plant
and food sciences.
Although funding by the European Community is limited
to a number of European expert scientists, COSMOS links to
major initiatives world-wide. For example with the US Na-
tional Institutes of Health (NIH) Common Funds Metabo-
lomics Initiative (http://commonfund.nih.gov/Metabolomi
cs/) which has awarded funding for six Regional Compre-
hensive Metabolomics Research Cores (RCMRC), and a
Data Repository and Coordination Centre (DRCC), to act as
a North American hub for metabolomics related research.9
COSMOS also reaches and establishes links with other re-
lated e-infrastructures initiative such as the new European-
wide ELIXIR project,10 Biobanking and Biomolecular
Resources Research Infrastructure11 (BBMRI) via
BioMedbridges12 consortium, Human Metabolome Data-
base (HMDB) in Canada (Wishart et al. 2013), Platform for
RIKEN Metabolomics (PRIMe) in Japan (Sakurai et al.
2013) and Beijing Genomics Institute (BGI)13 in China.
3.1 Metabolomics data exchange standards
The COSMOS work on standardisation aims to build on the
foundational work by PSI and MSI and further develop and
contribute to data exchange formats, ranging from raw data
in MS and NMR, the reporting of metabolite quantification
and metabolite identification, to the experimental metadata.
We aim to extend the open standards for MS data exchange
initiated by PSI, such as mzML (Martens et al. 2011), mzI-
dentML (Jones et al. 2012) and mzQuantML (Walzer et al.
2013) to meet the requirement of metabolomics experiments
for reporting MS experiments. One example are GC–MS
based metabolomics experiments, where data are often
available in either a closed vendor format or as netCDF,
where the latter provides only very fewmetadata acquisition
parameters and fails to capture advanced MS experiments
such as GC 9 GC–MS or tandem-MS with GC–MS in-
struments. This requirement led us to augment the PSI-MS
controlled vocabulary with GC specific terms and concepts,
which have already been included in the current PSI-MS
ontology. To avoid a chicken-and-egg problem, we have
collected raw data examples ‘‘in the wild’’; and checked
which GC–MS vendor formats can be converted to mzML.
Currently, file formats by Agilent Technologies, Bruker
Biosciences Corporation, Waters Corporation and Thermo
Fisher Scientific are companies that their file format is
readily supported by the Proteowizard Open Source con-
verter (Kessner et al. 2008; Chambers et al. 2012). Other
companies, such as LECO Corporation and Bruker Bio-
sciences in addition have software to export their file format
to mzML. On the consumer side, we surveyed which mzML
parsing libraries are available for the community. Parsers for
mzML exist for the languages C??, Java, R and Python,
2 ‘‘GigaScience.’’ 2011. 20 Aug. 2013 http://www.gigasciencejour
nal.com/.
3 ‘‘Scientific Data - Nature.’’ 2013. 20 Aug. 2013 http://www.nature.
com/scientificdata/.
4 Vinken ‘‘The carcinoGENOMICS project: critical selection of
model …’’ 2008. http://www.ncbi.nlm.nih.gov/pubmed/18514569.
5 ‘‘diXa.’’ 2012. 12 Mar. 2015 http://www.dixa-fp7.eu/.
6 ‘‘ToxBank | Data warehouse for toxicity data management.’’ 2010.
12 Mar. 2015 http://toxbank.net/.
7 ‘‘ArrayExpress\EMBL-EBI - European Bioinformatics Institute.’’
2008. 12 Mar. 2015 https://www.ebi.ac.uk/arrayexpress/.
8 ‘‘Home - SRA - NCBI.’’ 2009. 12 Mar. 2015\http://www.ncbi.
nlm.nih.gov/sra[.
9 ‘‘NIH announces new program in metabolomics.’’ 2012. 20 Aug.
2013 http://www.nih.gov/news/health/sep2012/od-19.htm.
10 ‘‘home | ELIXIR.’’ 2007. 20 Aug. 2013 http://www.elixir-europe.
org/.
11 ‘‘BBMRI: Home.’’ 2008. 20 Aug. 2013 http://www.bbmri.eu/.
12 ‘‘BioMedBridges: Home.’’ 2012. 20 Aug. 2013 http://www.
biomedbridges.eu/.
13 ‘‘BGI.’’ 2009. 20 Aug. 2013 http://www.genomics.cn/.
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which should cover the majority of the current software
developments in the metabolomics community, and we shall
of course supplement to these as necessary. Therefore,
mzML can be a strong suggestion or even a requirement for
data deposition in public repositories. Formats that capture
metabolite identification and reporting of quantification re-
sults also need to be adapted for MS metabolomics ex-
periments, and require real-world tests, software support and
community adoption. We hope to make COSMOS a plat-
form for community engagement with adaptation and de-
velopment of these formats to suit the metabolomics
community needs, and as mentioned above we regularly
consult with the Metabolomics Society. In addition, COS-
MOS developing the missing XML exchange formats for
NMR spectroscopy such as nmrML, nmrIdentML,
nmrQuantML and nmrTab needed by databases and open
source software such as NMRLab/MetaboLab (Ludwig and
Gunther 2011) Bayesian AuTomated Metabolite Analyser
for NMR spectra (BATMAN) (Hao et al. 2012) and rNMR
(Lewis et al. 2009). These developments take place onwww.
nmrml.org and https://github.com/nmrML/ and include the
XML schema, controlled vocabulary (Schober et al. 2014),
example files, and reader, writer, conversion and validation
software. As part of this approach we have begun and will
continue to interact with the wider community to ensure
wide adoption and call for implementations of the standards
during the design phase, which helps to catch design errors
before the standard is published. With semantic web tech-
nology in mind, these standards will pave the way for
metabolomics data to be part of the world of linked (and
open) data (Murray-Rust 2008). Preliminary work in cur-
rently underway, leveragingwork by the ISAteam in the field
of linked data to offer MetaboLights metadata content as
linked data (Gonza´lez-Beltra´n et al. 2014a).
3.2 Metabolomics databases and repositories
The power of broad, system-wide -omics relies on the po-
tential to interrogate datasets from new perspectives. Re-
searchers not involved in the original data generation process
may reuse data differently from the original purpose that
motivated the data collection. Unleashing this potential also
in the heterogeneous metabolomics landscape requires the
availability of metabolite level (ideally quantified) and
profile data along with adequate metadata. Therefore, the
COSMOS consortium is committed to develop the Meta-
boLights database further as a centralised data exchange and
storage platform. MetaboLights will serve as a common
publication hub and make it possible to connect different
resources while keeping the data interoperable (e.g. connect
to data in other resources, such as the NMC-DSP (van
Ommen et al. 2010)). In the metabolomics field, a large
number of custom and often technology focused, substance-
class, or species-centric databases exist and are continuously
developed for example; the Golm Metabolome Database or
GMD (Hummel et al. 2010) LipidMaps (Fahy et al. 2009),
PlantMetabolomics.org (Bais et al. 2010) and MeRy-B
(Ferry-Dumazet et al. 2011). Defining a sensible balance of
centralised versus decentralised information storage can be
resolved by developing and applying standards and ex-
change formats. Also, buy-in fromusers aswell as publishers
will have to be achieved. The journal Metabolomics, which
is the official journal of the Metabolomics Society, has since
2010 encouraged authors to ensure their papers are as MSI
compliant as possible (Goodacre 2010) and is committed to
supporting the COSMOS consortium in its endeavours for
metabolomics standardisation. This ethos is also being
adopted by other journals including Metabolite, EMBO and
others to join.
Integrative analysis of datasets is essential in order to
achieve better understanding of phenotypes. Moreover,
interfacing with dedicated databases utilising metadata
annotation tools will engage and enable a broad user base
to export data from their local systems into ISA-Tab for-
matted data sets, and subsequently to easily import or
submit to MetaboLights. MetaboLights and the ISA team
have been working on implementing principled curation
guidelines, ensuring consistency in the reporting of ex-
perimental designs. As a machine readable XML dialect,
the schema based XEML (Hannemann et al. 2009) pro-
vides means to store experimental design and metadata
describing the actual experiment, together with links to one
or more independent databases hosting the actual ex-
perimental results as well as export the results in ISA-Tab
format. The XEML-Lab sources and binaries for different
operating systems can be accessed and downloaded from
https://github.com/cbib/XEML-Lab.
In addition to the obvious breadth of experimental condi-
tions, the diversity of laboratory specific SOPs, even within
the most commonly employed measurement techniques such
as NMR and MS, renders the joint interpretation of data
produced by different labs difficult. Hence, standardised and
machine-readable metadata describing all aspect of ex-
perimental conditions are an essential prerequisite to allow a
quick, objective and hence meaningful selection of ex-
periments suitable for comparison. In a single-user environ-
ment, experimental metadata annotation can be efficiently
handled using the ISAcreator, part of the ISA software suite.
In addition, the COSMOS consortium also aims to develop
standards to connect to existing specialised databases such
as the GMD,MeRy-B, the NMC-DSP/dbNP, as well as other
similar resources using alternative metadata annotation tools
such as XEML (Hannemann et al. 2009) or the automatic
processing pipelines within Bioconductor packages (Gonza-
lez-Beltran et at. 2014b) and Bioportal powered ontology
(Maguire et al. 2013).
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3.3 Data deposition workflow
Making raw data available to the interested research
community has clear benefits to the transparency and
trustworthiness of those scientific studies. Scientists might
choose a variety of resources for their data deposition,
depending on their preferred technology. A comprehensive
workflow should protect data proprietary interests, security
(data will not be made publicly available until the associ-
ated publication has a bona fide DOI or the authors request
immediate data release), and confidentiality as required. To
ensure proper reporting of metabolomics data and metadata
(Salek et al. 2013c), COSMOS will set clear procedures for
data submission and deposition, as well as metabolomics
results reporting considering publishing requirements.
These will be in line with the existing MSI guidelines.
These guidelines are currently being carefully discussed,
elaborated and agreed by all COSMOS partners. COSMOS
is also taking every opportunity to engage fully with
stakeholders and potential collaborators on planning, dis-
cussion and implementation of the guidelines for data de-
position workflow. Careful planning of the data deposition
flow, its control policies and actions, will ensure that the
utility of the system is maximized and quality-controlled
for use inside and outside Europe. A proposed model for
the data deposition workflow, drafted from discussions
within COSMOS, is shown in Fig. 1. The workflow
definition will prioritize simplicity, usability, annotation
quality, the plurality of metabolomics resources and
databases, to ensure connectivity between similar studies
and to provide rapid matching results to the end users. We
envisage that in the future additional purpose-built
databases will be created that can potentially be integrated
into the proposed workflow. This will include Metabo-
Lights and the NIH funded Metabolomics Workbench.14
The first phase of the data deposition cycle is temporary
and all data and associated information are kept private.
Once the study has been officially published and the de-
positor agrees to share the data (making it open access), the
COSMOS ‘‘metabolomeXchange’’ system will auto-
matically announce and broadcast availability of such
studies to the broad research community (Fig. 2). In ad-
dition to the minimum required metadata (e.g. accession,
title, abstract, publication date, URL and submitters name),
the COSMOS ‘‘metabolomeXchange’’ system allows
datasets to be annotated using additional metadata infor-
mation. This would enable the metabolomics community
(both metabolomics researchers and databases) to query
efficiently and readily identify interesting and reusable
metabolomics data sets.
The default for most journals will be to promote open
access of the data as soon as the study is published, while
the accepted academic standard is to allow others to access
the work. All parties involved will benefit from sharing raw
data, processed data, metadata, statistical methods and
source codes. By increasing the visibility of their work,
depositors are likely to boost citations. Publishers and
journals will expose their publications to a greater number
of potential readers and enhance the overall impact of the
work. In addition, through COSMOS the research com-
munity will gain free access to a vast amount of well
documented and easy to access scientific information.
3.4 Coordination with BioMedBridges
and biomedical ESFRI infrastructures
COSMOS aims at building a network of close interactions
with the European biomedical infrastructures. A particular
interest is in the infrastructures for which metabolomics is
most relevant such as BBMRI, ELIXIR, EU-Openscreen,15
EuroBioimaging16 and EURODISH,17 all of which are
participating in the EC-funded project BioMedBridges.18
Our main objective is to obtain indicators, useful to pri-
oritize various COSMOS activities, in order to obtain ef-
fectively responses needed in large-scale EU biomedical
infrastructures. BioMedBridges and COSMOS are reason-
ably complementary as they address different levels of
information—COSMOS is more focused on the ex-
perimental side whereas BioMedBridges tackles the higher
complexity of human disease, investigated by a plethora of
different technologies, of which one is metabolomics.
Another important collaboration is COSMOS with
BBMRI. Human biobanks are structured resources that
store: (a) human biological materials and/or information
generated from the analysis of the same and (b) extensive
associated information. An emerging aspect would be the
usage of metabolomics as an efficient tool to monitor pre-
analytical sample variations as metabolites are known to be
prone to degradation phenomena, possibly more so than
other clinical biomarkers (e.g., DNA, RNA, proteins).
Another application of metabolomic profiling in relation to
biobanking is in assessment of quality and usage history for
samples and their collection, handling, traceability and
storage. Here COSMOS may play a key role in the de-
velopment of relevant required standardised formats.
14 ‘‘Metabolomics Workbench.’’ 2013. 20 Aug. 2013\http://www.
metabolomicsworkbench.org/[.
15 ‘‘WELCOME TO EU-OPENSCREEN.’’ 2009. 20 Aug. 2013
http://www.eu-openscreen.de/.
16 ‘‘Euro-BioImaging: Research Infrastructure for Imaging Tech-
nologies …’’ 2009. 20 Aug. 2013 http://www.eurobioimaging.eu/.
17 ‘‘EuroDISH: Home.’’ 2013. 18 Sep. 2013 http://www.eurodish.eu/.
18 ‘‘BioMedBridges: Home.’’ 2012. 20 Aug. 2013 http://www.
biomedbridges.eu/.
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Formal interactions between COSMOS and BBMRI are
being established to coordinate efforts: first, the coordina-
tor of BBMRI, has been nominated in the Advisory Board
of COSMOS; second, and also within the frame of BBMRI
(which specifically aims at integrating existing biomole-
cular resources, technologies, standards and know-how),
the University of Florence Magnetic Resonance Center
(CERM/CIRMMP) partner of COSMOS is establishing a
European multi-site Expert Center on metabolomics.
3.5 Outreach and dissemination
We will maintain a close link between the COSMOS
consortium and the wider metabolomics and biomedical
communities, as well as other related scientific fields. We
shall continue to use metabolomics workshops, meetings
and conferences to interact with the wider communities,
metabolomics or others, to get all parties involved with the
initiative. In addition, we will use publications and social
media, news articles and blogs to raise awareness of
metabolomics standards and the services provided by the
COSMOS consortium. This will be from data submission
to providing support on different views on how metabo-
lomics data may be reported. There is a great need for
increasingly stringent requirements for data quality that is
publicly available to the whole metabolomics community.
Through the existing framework of the Metabolomics So-
ciety, we will ensure broad community input into the ser-
vices and standards for metabolomics data representation
developed by COSMOS consortium, and it may come as no
surprise that several of the authors have served on one or
more of the Boards of the Metabolomics Society.
4 Concluding remarks
COSMOS will implement harmonised and compatible data
deposition strategies and contribute to annotation work-
flows, providing data producers involved in metabolomics
experiments with a single point of submission, while
allowing other data entry points through facilitation of in-
teroperability. The data deposition and exchange workflow
Fig. 1 Initial model for the COSMOS data deposition workflow
system. The data deposition cycle is initiated when a Submitter (who
has generated or owns the study material) submits his/her metabo-
lomics study to a specific associated database (1). Once the data
submission has been completed, fulfilling the requirement of the
associated repository submission guideline, a unique COSMOS
accession number will be generated. The COSMOS engine will then
properly annotate, format and store the minimum agreed metadata
according to proposed reporting standards suggested by COSMOS
partners (2, 3). COSMOS will bring together publishers and other
metabolomics repositories to come to final agreement on a data
workflow specifying minimum metadata exchange, associated raw
data, source code and any additional information that can be shared
(4, 5). Open access to the system will ensure that any interested party
can benefit from the standardized resources
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in the COSMOS consortium will be formally defined,
agreed, and documented in relation with MetaboLights and
all partnering databases in Europe and worldwide that
would like to participate, and we welcome discussions
from other data providers and software houses. A guideline
for submitted data will be generated and COSMOS will
strive to make sure that all metabolomics data submitted to
partner databases are exchangeable with this standard.
Since the adoption of minimal standards for metabolomics
by the relevant journals is a major goal of this coordination
action, we will consult with journal publishers and ensure
data annotation quality and consistency, according to the
required standard level set by each journal. For example,
collaboration with data journals such as GigaScience and
Fig. 2 COSMOS initiative workflow. Overview of COSMOS initia-
tive role in metabolomics standards, databases, data exchange and
dissemination of metabolomics experiments. Green metabolomics
labs experimental workflow from lab based data generation, metadata
collection to interaction with LIMS systems. Pink standardisation
initiative and minimum information reporting agreement involved or
used within the COSMOS project. Blue Dissemination and role of
journal and link to other e-infrastructures. White databases and tools
used to capture experimental data and metadata (Color figure online)
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Nature’s Scientific Data will be streamlined, given these
journals already use the ISA-Tab format for data submis-
sion. We are also working closely with Metabolomics,
which is the official journal of the Metabolomics Society.
The COSMOS consortium ultimately develops the
standards and infrastructure for—and with—the metabo-
lomics and fluxomics community. For the most efficient
interaction we have already, and will continue, to organise
stakeholder meetings as satellite events to major metabo-
lomics meetings, individual staff exchange between part-
ners, as well as larger workshops. These efforts will
directly enable the implementation of COSMOS important
deliverable—that of a robust data infrastructure and
mechanisms for standards metabolomics data representa-
tion and data/meta-data exchange that will enrich meta-
bolomics science.
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